Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
30 Janeiro 2024 - 6:05PM
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing
solutions, today announced its participation in the BTIG
MedTech, Digital Health, Life Science & Diagnostic
Tools Conference, which takes place February 13-14,
2024 in Snowbird, Utah. John Aballi, Exagen’s President
and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief
Financial Officer, will be participating in one-on-one
meetings with investors during the event; meetings can be requested
through BTIG.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its
purpose as an organization is to provide clarity in autoimmune
disease decision making with the goal of improving patients’
clinical outcomes. Exagen is located in San Diego County,
California.
For more information, please visit Exagen.com or follow
@ExagenInc on X (formerly known as Twitter).
Contact:Ryan DouglasExagen
Inc.ir@exagen.com760.560.1525
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024